sustainability: MSME Pharma companies under the lens over drug quality issues
More than 65% of MSME firms have been found to be manufacturing drugs that are not of standard quality (NSQ), during risk-based inspections of pharma companies conducted since December last year, said a person with knowledge of the matter.
Source: indiatimes.com